Sponsored & Endowed Lectures
The Novartis Lecture is sponsored by the Novartis Institutes for BioMedical Research (NIBR) to feature the most innovative scientists working in synthetic organic chemistry today.
Prof. Uttam Tambar
Department of Biochemistry
University of Texas Southwestern Medical Center
Catalytic Asymmetric Molecular Rearrangements
December 3, 2012
The Lambert Lecture is supported by an endowment established by alumnus Benjamin Lambert , who earned his bachelor’s degree in chemistry at Boston University (CAS ’55). After graduating from law school, he went on to pursue a distinguished career as a patent attorney with such major pharmaceutical companies as Merck and Johnhson & Johnson. Each year, the Lambert Lecture addresses different topics in organic chemistry, the field of Lambert’s undergraduate and graduate studies, and features some of the most distinguished and creative scientists working in the field of organic chemistry today.
Professor Larry E. Overman
Department of Chemistry
University of California, Irvine
Recent Studies in Stereoselective Synthesis of Bioactive Heterocycles
April 27. 2012
The lecture is sponsored by the journal, Organic Syntheses, to feature innovative scientists working in synthetic organic chemistry today.
Professor Daniel Romo
Texas A&M University
Bioactive Natural Products as Enduring Forums for Chemical Synthesis, Cellular Probe Discovery, and Identification of Therapeutic Targets
November 9, 2009
“Natural products continue to be versatile forums for synthetic strategy development, for identification of probes for basic cell biology, and lead discovery for human disease intervention. In this regard, the marine sponge isolate, pateamine A (PatA) from Mycale sp., has allowed us to explore each of these facets of natural products chemistry.
In more recent chemical synthesis efforts, we have developed novel strategies to gymnodimine, the seemingly simplest member of a class of spirocyclic imine-containing toxins for use as an immunogen for development of an ELISA assay for ocean toxin monitoring. Recent advances in our development of the nucleophile catalyzed aldol-lactonization (NCAL) process leading to bicyclic b-lactones has enabled a concise, A1,3-strain enabled, enantioselective synthesis of the potent proteasome inhibitor, salinosporamide and designed derivatives.”